1. Home
  2. GBIO vs AVD Comparison

GBIO vs AVD Comparison

Compare GBIO & AVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Generation Bio Co.

GBIO

Generation Bio Co.

HOLD

Current Price

$5.34

Market Cap

36.3M

Sector

Health Care

ML Signal

HOLD

Logo American Vanguard Corporation ($0.10 Par Value)

AVD

American Vanguard Corporation ($0.10 Par Value)

HOLD

Current Price

$3.88

Market Cap

108.7M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GBIO
AVD
Founded
2016
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Agricultural Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
36.3M
108.7M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
GBIO
AVD
Price
$5.34
$3.88
Analyst Decision
Buy
Strong Buy
Analyst Count
5
1
Target Price
$8.88
$12.00
AVG Volume (30 Days)
70.4K
209.2K
Earning Date
11-05-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$15,270,000.00
$530,073,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.54
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.00
$3.28
52 Week High
$12.40
$6.33

Technical Indicators

Market Signals
Indicator
GBIO
AVD
Relative Strength Index (RSI) 45.20 38.19
Support Level $5.40 $3.77
Resistance Level $5.77 $3.94
Average True Range (ATR) 0.21 0.14
MACD -0.01 0.01
Stochastic Oscillator 26.30 35.29

Price Performance

Historical Comparison
GBIO
AVD

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About AVD American Vanguard Corporation ($0.10 Par Value)

American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.

Share on Social Networks: